Nektar Therapeutics

Shares of $NKTR are up over 100% as the biotech company hit every goal in its midstage study for its eczema treatment. Looking at a long term monthly chart a break above about $25 could trigger a further push upwards.

Share this article:

About the Author:

Nektar Therapeutics

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup